QPPV.COM KNOWLEDGE ASSESSMENT

Potassium Chloride: Development, Replacement Therapy, Safety and Pharmacovigilance

Test your understanding of the concepts covered by Potassium Chloride: Development, Replacement Therapy, Safety and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A patient's serum potassium enters the reference range after replacement, but substantial gastrointestinal losses continue. Which interpretation is most appropriate?
Question 2 of 10 A patient taking the named US extended-release potassium chloride tablet is also prescribed amiloride. Which interpretation reflects the specific label described in the article?
Question 3 of 10 A patient has a markedly elevated potassium result from a haemolysed sample but no corresponding clinical findings. What is the best pharmacovigilance approach?
Question 4 of 10 A patient remains hypokalaemic despite prescribed oral potassium. Which assessment best avoids prematurely classifying the situation as product failure?
Question 5 of 10 A case narrative records that a patient received “potassium 20.” What is the most important next step for reliable dose assessment?
Question 6 of 10 Which case narrative best supports causal assessment when hyperkalaemia develops during potassium replacement?
Question 7 of 10 A reviewer observes that the US and French oral product labels differ in the specificity and location of gastrointestinal safety wording. What conclusion is justified?
Question 8 of 10 A maintenance potassium regimen was tolerated for months, but the patient then develops acute kidney injury. Why should the previous dose be reassessed?
Question 9 of 10 A patient with dysphagia is prescribed a solid oral potassium chloride tablet. Which safety consideration is most consistent with the article?
Question 10 of 10 Which conversion is consistent with the article's dose-unit guidance?

Select an answer to continue.

QPPV.com